Related content

Tumor markers for hepatocellular carcinoma (Review)

By      

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 593-598

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing

By Bassanello M.   Vitale A.   Ciarleglio F.A.   Brolese A.   Zanus G.   D'Amico F.   Carraro A.   Cappuzzo G.   Bridda A.   Senzolo M.   Burra P.   Pevere S.   D'Amico D.   Cillo U.  

Transplantation Proceedings, Vol. 35, Iss. 8, 2003-12 ,pp. : 2991-2994

Elsevier

Access to resources Recommend Favorite

Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series

By                          

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1028-1034

Spandidos Publications

Access to resources Recommend Favorite

Hepatic arterial infusion chemotherapy with gemcitabine and 5fluorouracil or oral S1 improves the prognosis of patients with postoperative liver metastases from pancreatic cancer

By                                                      

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 869-874

Spandidos Publications

Access to resources Recommend Favorite

Liver transplantation for hepatocellular carcinoma

By Jeng L.-B.   Lee W.-C.   Hung C.-M.   Yu M.-C.   Lee C.-S.   Chien R.-N.   Chiu C.-T.   Chen C.-C.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2171-2172

Elsevier

Access to resources Recommend Favorite